Free Trial

Cooper Companies (COO) Competitors

Cooper Companies logo
$88.48 -0.21 (-0.24%)
Closing price 02/21/2025 04:00 PM Eastern
Extended Trading
$88.28 -0.20 (-0.22%)
As of 02/21/2025 07:42 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

COO vs. WST, ALGN, MMSI, ICUI, XRAY, HAE, QDEL, NEOG, STAA, and CERS

Should you be buying Cooper Companies stock or one of its competitors? The main competitors of Cooper Companies include West Pharmaceutical Services (WST), Align Technology (ALGN), Merit Medical Systems (MMSI), ICU Medical (ICUI), DENTSPLY SIRONA (XRAY), Haemonetics (HAE), QuidelOrtho (QDEL), Neogen (NEOG), STAAR Surgical (STAA), and Cerus (CERS). These companies are all part of the "health care supplies" industry.

Cooper Companies vs.

Cooper Companies (NASDAQ:COO) and West Pharmaceutical Services (NYSE:WST) are both large-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their community ranking, risk, profitability, dividends, institutional ownership, valuation, analyst recommendations, earnings and media sentiment.

Cooper Companies presently has a consensus target price of $117.00, indicating a potential upside of 32.23%. West Pharmaceutical Services has a consensus target price of $344.00, indicating a potential upside of 63.25%. Given West Pharmaceutical Services' stronger consensus rating and higher probable upside, analysts clearly believe West Pharmaceutical Services is more favorable than Cooper Companies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cooper Companies
0 Sell rating(s)
2 Hold rating(s)
9 Buy rating(s)
0 Strong Buy rating(s)
2.82
West Pharmaceutical Services
0 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.83

West Pharmaceutical Services has lower revenue, but higher earnings than Cooper Companies. West Pharmaceutical Services is trading at a lower price-to-earnings ratio than Cooper Companies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cooper Companies$3.90B4.53$392.30M$1.9545.37
West Pharmaceutical Services$2.89B5.27$492.70M$6.6931.50

Cooper Companies has a beta of 1, indicating that its stock price has a similar volatility profile to the S&P 500.Comparatively, West Pharmaceutical Services has a beta of 1.01, indicating that its stock price is 1% more volatile than the S&P 500.

West Pharmaceutical Services has a net margin of 17.03% compared to Cooper Companies' net margin of 10.07%. West Pharmaceutical Services' return on equity of 18.60% beat Cooper Companies' return on equity.

Company Net Margins Return on Equity Return on Assets
Cooper Companies10.07% 9.38% 6.09%
West Pharmaceutical Services 17.03%18.60%13.80%

In the previous week, West Pharmaceutical Services had 5 more articles in the media than Cooper Companies. MarketBeat recorded 19 mentions for West Pharmaceutical Services and 14 mentions for Cooper Companies. Cooper Companies' average media sentiment score of 0.76 beat West Pharmaceutical Services' score of 0.36 indicating that Cooper Companies is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cooper Companies
10 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
West Pharmaceutical Services
6 Very Positive mention(s)
6 Positive mention(s)
5 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Cooper Companies received 351 more outperform votes than West Pharmaceutical Services when rated by MarketBeat users. Likewise, 66.38% of users gave Cooper Companies an outperform vote while only 56.04% of users gave West Pharmaceutical Services an outperform vote.

CompanyUnderperformOutperform
Cooper CompaniesOutperform Votes
620
66.38%
Underperform Votes
314
33.62%
West Pharmaceutical ServicesOutperform Votes
269
56.04%
Underperform Votes
211
43.96%

24.4% of Cooper Companies shares are owned by institutional investors. Comparatively, 93.9% of West Pharmaceutical Services shares are owned by institutional investors. 2.0% of Cooper Companies shares are owned by company insiders. Comparatively, 0.5% of West Pharmaceutical Services shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

West Pharmaceutical Services beats Cooper Companies on 11 of the 18 factors compared between the two stocks.

Get Cooper Companies News Delivered to You Automatically

Sign up to receive the latest news and ratings for COO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

COO vs. The Competition

MetricCooper CompaniesOphthalmic goods IndustryMedical SectorNASDAQ Exchange
Market Cap$17.66B$11.16B$5.77B$8.98B
Dividend YieldN/A1.63%4.78%3.85%
P/E Ratio45.3736.1126.4618.82
Price / Sales4.534.26455.0280.40
Price / Cash15.4714.6744.0437.47
Price / Book2.183.047.634.64
Net Income$392.30M$230.61M$3.18B$245.69M
7 Day Performance0.43%-1.61%-1.91%-2.66%
1 Month Performance-7.04%-7.71%-0.19%-2.15%
1 Year Performance-9.51%-12.30%16.70%12.90%

Cooper Companies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
COO
Cooper Companies
2.7525 of 5 stars
$88.48
-0.2%
$117.00
+32.2%
-9.8%$17.66B$3.90B45.3716,000
WST
West Pharmaceutical Services
4.9557 of 5 stars
$214.84
+7.9%
$344.00
+60.1%
-40.8%$15.56B$2.95B31.8710,600Dividend Announcement
Analyst Downgrade
High Trading Volume
ALGN
Align Technology
4.7933 of 5 stars
$206.77
+0.9%
$269.91
+30.5%
-37.5%$15.44B$4.00B36.8621,610
MMSI
Merit Medical Systems
3.6449 of 5 stars
$108.14
-0.2%
$109.80
+1.5%
+30.1%$6.30B$1.26B53.016,950Positive News
ICUI
ICU Medical
4.664 of 5 stars
$160.16
+1.2%
$199.67
+24.7%
+51.1%$3.92B$2.26B-35.0514,000News Coverage
XRAY
DENTSPLY SIRONA
4.86 of 5 stars
$18.32
-2.4%
$25.85
+41.1%
-43.3%$3.64B$3.97B-8.8515,000Analyst Upgrade
HAE
Haemonetics
4.7365 of 5 stars
$62.47
+0.3%
$101.67
+62.8%
-14.0%$3.14B$1.31B24.593,657Analyst Revision
QDEL
QuidelOrtho
4.7939 of 5 stars
$40.57
-2.6%
$51.20
+26.2%
-18.2%$2.73B$3.00B-1.457,100
NEOG
Neogen
3.7023 of 5 stars
$9.83
-0.9%
$14.00
+42.4%
-41.5%$2.13B$924.22M-4.492,110
STAA
STAAR Surgical
4.6378 of 5 stars
$15.35
-3.8%
$26.86
+75.0%
-44.5%$756.45M$322.42M34.891,115High Trading Volume
CERS
Cerus
2.8625 of 5 stars
$1.85
+2.8%
$3.63
+95.9%
-26.3%$343.57M$176.23M-16.82290Earnings Report
Analyst Forecast
News Coverage
Positive News

Related Companies and Tools


This page (NASDAQ:COO) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners